Discontinuation of TNF-alpha Inhibitors in Spondylarthritis Patients With Low Disease Activity, and Re-initiation of Therapy if Disease Flares.
Phase of Trial: Phase IV
Latest Information Update: 11 Jul 2016
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
- Indications Spondylarthritis
- Focus Biomarker; Therapeutic Use
- Acronyms SPARTA
- 31 Aug 2018 Biomarkers information updated
- 18 Aug 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
- 27 Mar 2012 Planned end date changed from 1 Dec 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov record.